Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for Verastem, Inc. Common Stock, $0.0001 par value per share (VSTM).
- Disclosed ownership: 3.9%.
- Date of event: 11 Aug 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 3.9% ownership in Verastem, Inc. Common Stock, $0.0001 par value per share (VSTM) on 11 Aug 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 2.2% | 1,396,290 | 0 | 1,396,290 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 2.2% | 1,396,290 | 0 | 1,396,290 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 1.5% | 933,240 | 0 | 933,240 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 1.5% | 933,240 | 0 | 933,240 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.2% | 100,150 | 0 | 100,150 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.2% | 100,150 | 0 | 100,150 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 3.6% | 2,329,530 | 0 | 2,329,530 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 3.9% | 2,500,000 | 0 | 2,500,000 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 3.9% | 2,500,000 | 0 | 2,500,000 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 3.9% | 2,500,000 | 0 | 2,500,000 | /s/ Mark N. Lampert | Mark N. Lampert |